Acelity L.P. Inc.
Acelity L.P. Inc., a leading global medical technology company headquartered in the United States, specialises in advanced wound care and regenerative medicine. Founded in 1976, Acelity has established itself as a pioneer in the industry, focusing on innovative solutions that enhance patient outcomes. With a strong presence in North America, Europe, and Asia-Pacific, the company offers a diverse range of products, including advanced wound dressings and biologics.
Acelity's unique offerings, such as the KCI brand of negative pressure wound therapy, set it apart in the competitive landscape. The company has achieved significant milestones, including numerous patents and awards for its cutting-edge technologies. As a trusted partner in healthcare, Acelity continues to lead the way in transforming wound care and improving the quality of life for patients worldwide.
-22 vs industry average
Acelity L.P. Inc.’s score of 18 is lower than 33% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Acelity L.P. Inc.?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Pharmaceutical Preparation Manufacturing is among the least carbon-intensive industries
Industry performance
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
Reported emissions
No reported emissions data is available for Acelity L.P. Inc. yet.
Acelity L.P. Inc.'s reported carbon emissions
Acelity L.P. Inc., headquartered in the US, currently does not have available carbon emissions data for the most recent year, nor does it report any specific reduction targets or climate commitments. The absence of emissions data suggests that the company may not have publicly disclosed its carbon footprint or related initiatives. Additionally, there are no climate pledges or commitments to science-based targets (SBTi) reported, indicating a potential gap in their climate strategy.
As Acelity operates within the medical technology sector, it is essential for the company to consider industry standards for emissions reporting and reduction. The lack of disclosed emissions data and targets may impact its reputation and alignment with global sustainability goals. Without specific initiatives or commitments, Acelity's approach to climate action remains unclear.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Acelity L.P. Inc.’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Acelity L.P. Inc. yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Emissions comparison with industry peers
View similar organisations
Acelity L.P. Inc.
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project